Open AccessNanosponges: Blooming NDDS in the Future perspective
Author(s) -
Alka Singh,
Chetan Singh Chauhan
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v70i02.026
Subject(s) - disease , pandemic , drug development , covid-19 , antiviral drug , medicine , intensive care medicine , virology , drug , nanotechnology , infectious disease (medical specialty) , virus , pharmacology , materials science , pathology
From the history of human civilization, it has been noted that the microorganisms are the cause of various pandemics and epidemics.Among all microorganisms viruses are notorious. Viruses are intracellular parasites having RNA and DNA as their genetic material.When these disease-causing viruses enter in host cell they start, to replicate and cause chronic illnesses. In such conditions antiviraldrugs are used to inhibit the activity of these viruses to prevent the illness. From the previous data of development of antiviral therapy,it is found that nanotechnology plays a vital role in the development of nanomedicines in this field, the major problem arises is thedevelopment of resistance by the viruses for certain drugs. Nanosponges is a new drug delivery system of a combination of scienceand engineering in the area of medicine that full fill the current state of treatment of various life-threatening diseases. Thenanomedicines comprise nanoparticles to advanced nanosponges which enables the use of biocompatible nanomaterial in treatmentand prevention of various severe disease like SARS Covid-19. Therefore, researchers are focusing on the new aspect of drugdevelopment. This review focuses on the various advancement of nanosponges to develop suitable antiviral therapy to combatundesirable effects of SARS, Covid-19.